Analysis of Malignant Effusions by Cellular Composition, Proliferation Kinetics, and In Vitro Clonogenicity

  • V. Hofmann
  • M. E. Berens
  • U. Früh
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 94)


The human tumor clonogenic assay (HTCA) has received wide international attention and has been introduced in numerous laboratories since its original description by Hamburger and Salmon (1977). The dominant adavantage of the HTCA is its specificity for selecting neoplastic clones to the exclusion of other cellular elements. The neoplastic origin of cells comprising colonies has been confirmed by light and electron microscopy (Salmon and Liu 1979; Harris et al. 1982), production of tumor markers (Von Hoff et al. 1980), cytogenetics (Trent and Salmon 1980), and colony transplants into nude mice. Furthermore, it is believed that tumor clones growing in semisolid agar represent the cell fraction responsible for in vivo tumor propagation.


Label Index Malignant Effusion Proliferation Kinetic Semisolid Agar Neoplastic Clone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Durie BGM, Salmon SE (1975) High speed scintillation autoradiography. Science 190: 1093–1095PubMedCrossRefGoogle Scholar
  2. Durie BGM, Salmon SE (1980) Cell kinetic analysis of human tumor stem cells. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 153–163Google Scholar
  3. Hamburger AW, Salmon SE (1977) Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846–854PubMedCrossRefGoogle Scholar
  4. Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS, Schmidt HJ (1978) Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 38: 3438–3444PubMedGoogle Scholar
  5. Harris GJ, Zeagler J, Hodach A, Casper J, Harb J, Von Hoff DD (1982) Ultrastructural analysis of colonies growing in a human tumor cloning system. Cancer 50: 722–726PubMedCrossRefGoogle Scholar
  6. Hofmann V, Berens ME, Martz G (to be published) Drug selection for perioperative chemotherapy. In: Metzger U, Senn HJ, Largiader F (eds) Recent results in cancer research.Google Scholar
  7. Kurland JI, Broxmeyer HE, Bockman RS, Moore MAS (1979) Role of monocyte-macrop age-derived colony stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. Blood 52: 388–407Google Scholar
  8. Ludwig C, Hicks Mi, Pena B, Durie BGM (1983) OKT-8+-Suppressor-T-Lymphozyten sind bei Patienten mit stabilem multiplem Myelom vermehrt. Schweiz Med Wochenschr 113: 1451–1454PubMedGoogle Scholar
  9. Meyskens FL (1980) Human melanoma colony formation in soft agar. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 85–99Google Scholar
  10. Salmon SE, Liu R (1979) Direct “wet” staining of tumor or hematopoetic colonies in agar culture. Br J Cancer 39: 779–781PubMedCrossRefGoogle Scholar
  11. Trent JM, Salmon SE (1980) Human tumor karyology: marked analytic improvement by short-term agar culture. Br J Cancer 41: 867–874PubMedCrossRefGoogle Scholar
  12. Von Hoff DD, Harris GJ, Johnson G, Glaubiger D (1980) Initial experience with the human tumor stem cell assay system: potential and problems. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 113–124Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1984

Authors and Affiliations

  • V. Hofmann
    • 1
  • M. E. Berens
    • 1
  • U. Früh
    • 1
  1. 1.Department für Innere Medizin, Abteilung für OnkologieUniversitätsspital ZürichZürichSwitzerland

Personalised recommendations